GSCG announces an on-site course at OHIO
Global Stem Cells Group (GSCG) has announced a new on-site training course to be conducted through the International Society for Stem Cell Application (ISSCA) in Ohio. This on-site training course will be presented as a total solution to teach and train medical practitioners on the most recent advances in cellular-based treatments and regenerative medicine. It demonstrates the growing demand for clinics and doctors to integrate regenerative medicine into their services.
Personalized Hands-On Training with Industry-Leading Instructors
The new on-site training course to be conducted in Ohio will offer a personalized, hands-on approach, bringing industry leading instructors to the trainees’ clinics. “This course takes a highly visual and interactive angle, which provides trainers with the ability to teach reintegration and procedural techniques on live patients using different protocols for isolating stem cells – right from their own medical establishment,” says Benito Novas, CEO of the GSCG.
The on-site training course will include and offer the following:
Fully Dedicated Instructors
The hands-on approach to this training course involves using industry-leading instructors to offer one-on-one learning. It is the best and most effective way of learning, understanding, and becoming skilled at adipose stem cells and bone marrow extraction procedures.
Staff Training
Doctors usually delegate the process of PRP isolation and obtaining stem cells from bone marrow or fat to their nurses and medical assistants because the procedures are methodical. However, nurses and medical assistants must be fully trained and skilled in these fields. This course imparts them with the relevant skills, enabling them to perform these procedures when doctors need their help.
Trainees’ Preferred Treatment Protocols
This will be a personalized training course, so trainees can choose the treatment protocols they want to learn about and the illnesses they want to target. The instructors will teach not only the process of obtaining cells; they will also reintegrate the cells into the patient and teach about the various reintegration methods based on the patient’s medical conditions.
Equipment & Kits
Isolating and reintegrating stem cells requires the use of certain equipment and kits. The administrators will deliver and install the required equipment, kit, and consumables in the trainees’ clinics.
The Scheduling Process
This course is fully personalized, meaning trainees will have varying needs and preferences. The ISSCA will conduct an initial consultation to discuss the types of treatments trainees want to learn, the patients they need to schedule for treatment, and the underlying costs. The information provided during the initial consultation will enable the ISSCA to gather the relevant supplies, equipment, and training materials for each training session.
About Global Stem Cell Group (GSCG)
Global Stem Cells Group is the parent company of six companies that are dedicated to stem cell research, solutions, and technology training. The group was founded in 2012 and combines dedicated researchers, patient educators, and physician trainers with the shared goal of meeting the need for high-end stem cell solutions and treatments.
Given that the group has a singular focus in this field, it is uniquely positioned to become the global leader in cellular medicine. In addition, by bringing together leading professionals in cellular medicine, it can discover issues that the industry faces and focus its research and development in this area. This specialization has, undoubtedly, enabled it to come up with solutions that address some of the significant issues that most stakeholders are facing in the industry.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
About the International Society for Stem Cell Application (ISSCA)
ISSCA is a multidisciplinary community of physicians and scientists working together to advance science, technology, and the practice of regenerative medicine to treat diseases and lessen human suffering. The group aims to assume a leadership position in regenerative medicine’s research, publication, education, training, and certification standards. ISSCA adopts a hands-on approach by offering certification training worldwide, spreading the practice of regenerative medicine.
- Published in Press Release
Announcement Of Additional Training Days For Cell therapy Certification in Cancún
The International Society for Stem Cell Application (ISSCA) announced that it would conduct a regenerative medicine certification training course in stem cell therapy in Cancun, Mexico, from 7th to 8th October. Now, the ISSCA is thrilled to announce that the original training course has been sold out. Those still interested in taking this stem cell therapy course will also be glad to know that the ISSCA has scheduled a new opening date: from 9th to 10th October.
This announcement is driven by the growing demand for doctors in Mexico to learn and include stem cell therapy in their services. “We are excited to learn that our upcoming course on cell therapy in Cancun, Mexico has sold out, which shows that more and more physicians want to implement regenerative medicine in their clinics,” says Benito Novas, Founder and CEO of Global Stem Cells Group (GSCG). ISSCA is an educational division of GSCG.
New Opening Date, Same Training Course
There is a new date open to doctors who were not able to register on the original date..The skills and lessons taught remain the same, giving trainees in the second shift access to the same knowledge as those in the original shift.
This two-day course will teach how to harvest bone marrow and adipose stem cells from patients in a clinical setting. It is designed for physicians and high-level practitioners.
The first day will cover the course’s theoretical portion, familiarizing the doctors with the subject. The second day will then cover the course’s practical portion using live cases of various clinical applications of stem cells and exosomes in a clinical setting.
Doctors will learn skills to help them treat their patients more effectively. These skills will also help advance their careers, especially considering the growing importance of stem cell therapy across multiple medical fields. The course will only be available for eight people, so time is of the essence for those who wish to book a spot. Visit https://cursocelulasmadre.com/cursosde-certificacion/cursos-presenciales/ to learn more about the course and register.
About the Global Stem Cells Group (GSCG)
GSCG is a global network of seven major medical corporations exploring various ways of advancing technological and scientific advancements in stem cell development, treatment, and training.
The advancements achieved by GSCG enable it to provide medical practitioners with stem cell solutions that are compliant with the highest medical standards. The company is also publicly traded under the symbol MSSV.
About the International Society for Stem Cell Application (ISSCA)
ISSCA is the educational division of GSCG. It is also a multidisciplinary group of scientists and physicians exploring various ways of advancing the technology, science, and practice of regenerative medicine. The group aims to assume a leadership position in regenerative medicine’s research, publication, education, training, and certification standards. ISSCA has trained more than 10,000 physicians worldwide and adopts a hands-on approach by offering certification training worldwide, spreading the practice of regenerative medicine. Their main goal is to treat diseases more effectively, thereby reducing human suffering.
- Published in Press Release
Global Stem Cells Group Announces the Launch of a New Bone Marrow Harvesting Kit
The Global Stem Cells Group has announced the launch of a new bone marrow harvesting kit in response to a request for effective and accessible solutions to regenerative medicine procedures
Bone marrow is a spongy tissue that is located inside most large bones – it is essential for generating red blood cells (erythrocytes), white blood cells (leukocytes) and platelets (thrombocytes), using a bone marrow aspirate needle to collect the aspirate can help physicians perform different regenerative treatments especially in osteomioarticular conditions.
Increased Stem and Progenitor Cell Concentrations in Marrow Aspiration
According to the company, the new kit for processing and extraction of pure bone marrow has demonstrated its ability to increase stem and progenitor cell concentrations in marrow aspiration compared to traditional needles. It further adds that the device overcomes the limitations of traditional needles that restrict the amount of peripheral blood that would otherwise have been aspirated by forcing aspiration flow through side ports rather than from an open cannula. This setup has been a major issue with traditional needles and often led to the extraction of excessive amounts of bone marrow as well as impure marrow.
“Cellgenic plans with this new device to position itself as a leader in the development and manufacture of single-use medical devices for a number of medical specialties, we have developed a new bone marrow aspiration and biopsy needle that is manual, sterile and disposable, allowing precise procedures to be performed” said Benito Novas C.E.O of Global Stem Cells group
The new system offers the facility for doctors to reposition the needle more precisely at different access points. Precision is vital when trying to access bone marrow from specific sections of the bone.
According to Benito Novas, CEO of Global Stem Cells Group, the product will be launched at a press conference this September in Istanbul, Turkey within the framework of the World Congress of Regenerative Medicine. Additionally, it will be available at retail for doctors and distributors worldwide from October 2022
Buyers will undergo an orientation to use the new kit. It is easy to work with and many are expected to start using it as soon as they purchase it. The stem cells group will offer all the necessary training and support for the doctors during training and thereafter to ensure that the medical practitioners enjoy the full benefits of the device.
Global Stem Cells Group has been on the frontline in offering quality devices for stem cell procedures. It aims to make procedures as simple, risk-free, and efficient as possible for the maximum benefit of patients.
About Global Stem Cells Group
Global Stem Cells Group is the parent company of six companies that are dedicated to stem cell research, solutions, and technology training. The group was founded in 2012 and combines dedicated researchers, patient educators, and physician trainers with the shared goal of meeting the need for high-end stem cell solutions and treatments.
Given that the group has a singular focus in this field, it is uniquely positioned to become the global leader in cellular medicine. In addition, by bringing together leading professionals in cellular medicine, it can discover issues that the industry faces and focus its research and development in this area. This specialization has, undoubtedly, enabled it to come up with solutions that address some of the significant issues that most stakeholders are facing in the industry.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
- Published in Press Release
ISSCA Announces the Regenerative Medicine World Congress Speaker list and Promgram
The International Society for Stem Cell Application (ISSCA) has announced the Regenerative Medicine World Congress 2022 that will take place at the Radisson Blu Hotel in Istanbul, Turkey, between September 23rd and 25th, 2022. The congress brings together world-class doctors and scientists from over 35 countries.
Participants at the congress will have a rare chance to listen to over 25 world-leading medical experts as they make evidence-based research presentations on various issues related to stem cell therapy and regenerative medicine via evidence-based presentations.
Highlights of the Congress
Interactions with World-Class Speakers
Participants at the congress will have a chance to engage scientists and physicians with extensive experience applying cellular therapies and regenerative medicine in clinical environments. It will be an opportunity to gain insights into the industry and applications of this technology.
Updates on the Latest Products and Technologies in Regenerative Medicine
Some items to be discussed at the congress include new technologies, the latest products and equipment in regenerative medicine, and cellular studies. Participants will access these technologies and understand how they play a part in developing solutions to different problems in the medical field.
Hands-on Training by Leading Instructors
Participants will get two days of intensive training on clinical and aesthetic applications of stem cell therapy as part of the workshop. This training will be provided by ISSCA-certified instructors with experience in the particular areas that they will be handling. On the third day. participants will participate in live practical lessons on areas lectured on in the last two days. However, the practical lessons will be limited to 20 seats and available only to participants who purchase the all-access package.
An Opportunity to Network
Doctors and scientists will get an opportunity to network with like-minded professionals from different parts of the world to expand their knowledge and be part of a growing team of innovative minds who are leading the future of medicine. Participants will have the opportunity to interact, share ideas, and contact fellow professionals and speakers at the congress.
The Program
The president of ISSCA. Dr. Dayeong Kim (Korea). will open the program before the rest of the instructors take the stage. This team will tackle diverse areas that show the use of stem cell therapy in various medical conditions and real-world cases where the technology is being applied. Participants will get a chance to gain insights and expand their thoughts on the matters surrounding the use of stem cell technology to deal with various medical conditions.
Conference Packages
There are two packages for the conference. The first package will give participants access to two-day lectures on September 23rd and 24th. This package is going for $499.
The second package, dubbed “All-Access.” will include the one-day hands-on certification at ReGen iC Clinic on September 25th. in addition to two two-day lectures. This package will go for $950.
There are only 20 seats in the All-Access package. You can reserve a seat in either of the packages by purchasing the ticket on the ISSCA website.
More information regarding the conference can be found on the ISSCA website.
- Published in Press Release
ISSCA Offers New Online Post-graduate Program in Regenerative Medicine and Advanced Therapies
With video lectures and additional tools from some of the most respected names in today’s stem cells field, the course arms practitioners with the necessary knowledge and resources to offer innovative regenerative medicine treatments in their existing practices.
MIAMI, Florida— The International Society for Stem Cell Application (ISSCA) has announced it has launched a new online Post-graduate Program in Regenerative Medicine and Advanced Therapies. The course adds to the group’s already existing robust offering of onsite and online courses designed to give physicians looking to incorporate regenerative medicine protocols into their practices the education and tools necessary to do so.
Regenerative medicine has been increasingly gaining attention in today’s fast-paced medical world. As more researchers and physicians become interested in studying the field and introducing treatment protocols into their practices, it can be difficult to know which products and practices yield the best results for patients seeking these treatments for relief from degenerative diseases, noted Dr. Silvina Pastrana, main professor of the program and medical director of the stem cell center in Buenos Aires. Knowing which products work for which conditions and how to safely administer them to maximize results are key in leading a successful regenerative medicine practice.
With the new online Post-graduate Program in Regenerative Medicine and Advanced Therapies and others offered by the ISSCA, physicians will learn these valuable protocols and more about product offerings and how to choose the most effective ones. The Post-graduate Program will prepare physicians with the necessary theoretical and practical knowledge needed to effectively and safely secure better patient outcomes when using cellular therapies. With this training, physicians will gain knowledge from leading scientists in the field, learn valuable information on safety standards and quality control from top manufacturers, be positioned to perform these procedures and open a Stem Cell Center practice, join the ISSCA’s network, and enjoy the benefits of an exponentially growing industry worldwide.
Physicians looking to enroll in this online Post-graduate Program and other offerings by the ISSCA are in good hands. The group is widely considered as the global standard bearer when it comes to education and research in the regenerative medicine field. For years, the ISSCA has played a critical role in bridging the gap between the science behind stem cells and regenerative medicine and the practical application of that science in a clinical setting.
“We are pleased to add the online online Post-graduate Program in Regenerative Medicine and Advanced Therapies to our growing number of course offerings designed to deliver the skills and education needed to practitioners eager to implement stem cells treatment protocols into their existing practices,” said Benito Novas, ISSCA VP of Public Relations. “The program gives physicians the skills needed to utilize these highly effective treatments to help patients suffering from degenerative diseases while expanding on the ISSCA’s mission to continue to serve as the premier educational resource for physicians across the globe looking to introduce stem cells treatments into their practices.”
To learn more about the ISSCA, visit www.issca.us. To learn more about the group’s new online Cellular Therapy course or to register, visit https://cursocelulasmadre.com/cursos-de-certificacion/posgrado-en-medicina-regenerativa-y-terapias-avanzadas/
- Published in Press Release
GSCG Announces Upcoming Stem Cell Training Course in Dubai
The Global Stem Cells Group, a multi-disciplinary community of scientists and physicians that are collaborating to treat diseases and lessen human suffering through the advancement of the field of regenerative medicine has announced plans for a training in Dubai, UAE on November 11th-12th.
This training will be one of the second one of 2022, reaffirming the Global Stem Cells Group’s presence in Europe as a key player in the field of regenerative medicine. Members from both Global Stem Cells Group & the International Society for Stem Cell Application’s Dubai Chapter will be there to assist in expanding research for and the practice of regenerative medicine across Europe.
“We hope that more and more physicians and clinics will take up the benefits of regenerative medicine.As we continue to train patients with the GCell Machine, ” Says Benito Novas, founder and CEO of the Global Stem Cells Group
This training is intended to teach physicians the value and process behind incorporating regenerative medicine into their own clinical practice. This includes a theoretical portion that goes over basic regenerative medicine biology and its application, but also includes a Hands-On portion in which doctors, in a controlled environment and guided by a team of medical professionals, will have the opportunity to see procedures be performed just a few feet away, and then get the opportunity to try it for themselves.
This training will also teach physicians how to utilize the GCell Machine to perform regenerative medicine therapies. GCell is a tissue homogenization device that is revolutionizing the future of regenerative medicine. It is an extremely compact, all-in-one unit that can homogenize and isolate the stem cells from an adipose sample. GCell’s process of homogenizing with a system of precise blades and filtering ensures that the sample can be processed within an hour, with little input from the physician when the machine begins to do its work.
Once the process is over, the end result is a final product that can be administered to patients within an hour after the initial tissue extraction. This is a far cry from the previous, muti-hour long treatments that physicians have grown accustomed to, and the shortened timespan and simplicity of the procedure is something that both doctors and their patients will greatly appreciate.
If you are interested in enrolling in this upcoming event, or to learn more about the different training opportunities available, you can visit us at our training website.
About Global Stem Cells Group
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
- Published in Press Release
Global Stem Cells Group Announces Training in Lima, Perú
MIAMI,Florida—The International Society for Stem Cell Application (ISSCA) has announced plans to hold a Cell therapy Certification training course for qualified physicians in Lima on December 09 and 10, 2022.
Each participating physician obtains the intellectual property of 22 proprietary protocols that will them to treat degenerative and aesthetic diseases and conditions in their offices. Step-by-step videos of each protocol are provided to physicians for later referral.
Participating physicians acquire the skills necessary to offer an alternative therapy to patients with medical conditions for which no solution is currently available. ISSCA’s stem cell training course allows qualified physicians who earn certification to offer sought-after alternative treatments.
Successful completion of the ISSCA regenerative medicine certification course allows physicians to join a select group of practitioners at the forefront of medical science. Only 5 percent of physicians worldwide access to stem cell therapy studies, and so far only 0.01 percent are practicing these therapies.
The course also provides participating physicians with access to ISSCA’s online stem cell training course to review all content and procedures introduced during the two-day clinical training course, as well as patient forms and guidelines, procedures, informed consent forms, didactic lectures, training booklets, and more,
The ISSCA’s regenerative medicine protocols training course was developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells derived from patients’ adipose tissue and bone marrow.
Seating is limited to eight participants. Register today at the Lima Peru course website to secure a seat, email info@stemcellsgroup.com, or call +1 305 5605337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. The ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
- Published in Press Release
ISSCA Regenerative World Congress opens a new date for hands-on practice
ISSCA has opened a new date for hands-on experience at the World Congress of Regenerative Medicine.
The International Society for Stem Cell Application (ISSCA) has announced a new date for practical certification at the 2022 World Congress of Regenerative Medicine in Istanbul, Turkey. The nonprofit association was compelled to open a new date by the growing demand for doctors to have clinical experience with real patients at the ISSCA World Congress.
This year’s conference was initially scheduled to take three days. The first two days (Sep 23-24) will be days of engaging and interactive conferences and lectures by prestigious physicians from all over the world. The doctors will mainly talk about basic science, current science, and clinical experience.
The event’s final day (Sep 25) would be dedicated to practical experience in the clinic. The high demand for the congress means it’s completely sold out, but the company decided to open a new date for training, extending the event to September 26.
To provide detailed information on the different training and certification programs in the framework of the World Congress, ISSCA launched a website where the agendas of various days and different packages are shown. Purchasing the full package gives a participant access to the conference and hands-on practice—for example, https://www.issca.us/issca-announces-the-programagenda-of-regenerative-medicine-world-congress-2022/.
What to Expect at the ISSCA World Congress of Regenerative Medicine
ISSCA spearheads research and the benefits of Regenerative Medicine to countries worldwide. The annual World Conference is organized to accelerate the advancement of cellular therapies, related technology, and clinical applications. The event draws an international congregation of world-class scientists and doctors from over 30 countries globally for three full days of conferences, lectures, and clinical application workshops.
This year, senior medical leaders and researchers will speak with panels about the recent trends and advancements in the field of regenerative Medicine, with a high focus on the following three topics:
- Molecular Biology
- New treatment models in surgical and cosmetic applications
- The latest innovations in regenerative Medicine
The conference will also discuss the legal implications of the practice of regenerative Medicine as it spreads throughout the world. That’ll ensure multiple governments have the resources and input they need to create favorable policies.
ISSCA Regenerative World Congress opens a new date for hands-on practice The International Society for Stem Cell Application (ISSCA) is dedicated to promoting the highest standards and excellence in the field of Regenerative Medicine and the related education, certifications, and publications. The company comprises a team of interdisciplinary and innovative physicians and researchers driven by one common goal – to advance the science, technology, and practice of Regenerative Medicine to treat diseases and alleviate human suffering.
- Published in Press Release
ISSCA Announces the Program Agenda of Regenerative Medicine World Congress 2022
The International Society for Stem Cell Application (ISSCA) is hosting the most anticipated regenerative medicine event of he year – Regenerative Medicine World Congress 2022. The congress will take place at the Radisson Blu Hotel Istanbul Sisli, Turkey, on September 23. 24. and 25.
The congress features theoretical lectures on the first two days. Physicians and scientists from around the world will present evidence-based research: demonstrate updates on technologies. products, and equipment: share their extensive experience in clinical applications of regenerative medicine and cellular therapies. 30 presentations focusing on stem cell research and regenerative medicine will be given by clinicians and researchers in different specialties. Featured topics include:
- Mesenchymal stem cells (MSC)
- Exosomes
- Plastic and reconstructive surgery
- Clinical trials
- Nerve injury treatment
- Applications in ophthalmology and cardiology
- Immunotherapy
The congress will be the ultimate gathering and a showcase of the most cutting-edge research in regenerative medicine. Congress participants will be able to network with like-minded medical professionals from different parts of the world and become part of a growing community leading the future of medicine.
With the All-Access package, congress participants will have access to the hands-on practice certification portion on the third day. The live practical portion has only 20 limited seats available.
ISSCA-certified instructors, Dr. Maritza Novas (Director of Research and Development at Global Stem Cells Group. USA) and Dr. Melihcan Sezgic (Plastic. Reconstructive and Aesthetic Surgeon. Regenerative Medicine Specialist. Turkey), will lead one-on-one training sessions at the ReGeniC Clinic. This is a great opportunity to gain intensive hands-on experience in the aesthetic and clinical applications of stem cell therapy. The following training modules are included:
Cellular Products
- Mononuclear layer umbilical cord blood
- Exosomes: Characterization, examination of growth factors and cytokines
- Amniotic fluid and its action as a natural anti-inflammatory
Production, Manufacturing, and Quality Control
- Eligibility and selection of donors
- Collection and management of samples
- Processing and laboratory standards
- Testing and validation of quality control
Protocol Discussion
- Clinical framework for therapeutic applications
- Protocol details and supporting scientific literature
- Product storage and preparation
- Selection of patients
- Results and expectations of patients
Application of the Protocol in Live Patients
- Demonstration of product preparation and injection
About ISSCA
The ISSCA is a multidisciplinary community of physicians and scientists with a mission to advance the science, technology, and practice of Regenerative Medicine to treat disease and lessen human suffering. Its members are leaders in setting standards and promoting excellence in regenerative medicine, related education, certification, research and publications.
The Regenerative Medicine World Congress 2022 will be one of the most celebrated events of the year. where we share the ISSCA values in Integrity, Interdisciplinary, and Innovation. The ISSCA invites physicians and healthcare professionals devoted to regenerative medicine to expand their network, access world-class speakers, and update themselves with the latest technologies, products and equipment.
For more information. please fill out the form to contact us.
- Published in Press Release
ISSCA WILL PARTICIPATE IN VII CONGRESO INTERNACIONAL MEDESTETICA 2022: ARGENTINA
The international society for stem cell association (ISSCA) will participate in VII CONGRESO INTERNACIONAL MEDESTETICA 2022 at Paseo La Plaza. Buenos Aires, Argentina, on August 11, 12 and 13.
ISSCA has announced plans to participate as a sponsor in the medestetica congress. The organization has been promoting advances in regenerative medicine especially focused on the aesthetic field and will continue to explore new medical events like CONGRESO MEDESTETICA to educate the Argentine medical community
As part of the program ISSCA faculty members will have a presentation and a practical workshop showing the latest application of regenerative medicine. ISSCA complete program will cover all the different topics related to regenerative medicine applications, guidelines and clinical protocols
About the Speakers
Dr. Maritza Novas
Dr. Maritza is a research and Development Director of Global Stem Cells Group in the USA. She is a pioneer in using cell therapies for therapeutic procedures. pain management. and aesthetic applications. She has an outstanding reputation for training over 2000 physicians globally on procedures and protocols for harvesting and isolating adipose-derived stem cells for autologous and allogeneic reim plantation. She will be covering the topic of Allogeneic Therapies and stromal cell exosomes.
Dr. Silvina Pastrana
She is a chapter director of ISSCA in Argentina and medical director of the stem cell center in Buenos Aires. Dr. Silvina is a Regentherapy s.a. medical surgeon. She has a master’s in aesthetic and anti-age medicine (AMA). an Ozonologist. and a master’s in pain management. Her topic in this congress will be Fundamentals of cellular therapies: mesenchymal cells.
Dr. Andrea Lapeire
She is an aesthetic medical practitioner with a postgraduate in obesity. biological medicine. homotoxicology. and environment. Her workshop demonstration will be on advanced regenerative medicine in alopecia and its basics.
Prof. Dr. Julio Ferreira
He is from Argentina is a professional cosmetic surgery and aesthetic medicine expert. He is a university professor of medicine and is the president of the South American Academy Of Aesthetic Surgery. He will cover regenerative therapies in rejuvenation and facial harmonization in the workshop.
Benito Novas
Benito Novas is the managing director of the International Society for Stem Cell Application from the USA. He is the senior marketing consultant and founder of “Este’tica marketing INC”. as an Author. he has authored several books among them: su clinica este’tica. Lo que dicen sus pacientes” Marketing Digital en su Clinica Estetica” and “Marketing en Tiempos de Crisis” for more information on Novas you can check on www.benitonovas.com. In this congress. Benito Novas will be covering Digital Marketing in Cash-based practices.
ISSCA at Global Perspective.
ISSCA has been at the forefront of promoting excellent and standardized regenerative medicine. For more information and updates. visit us at https://www.issca.us/
The ISSCA is a multidisciplinary community of physicians and scientists with a mission to advance the science, technology, and practice of Regenerative Medicine to treat disease and lessen human suffering. Its members are leaders in setting standards and promoting excellence in regenerative medicine, related education, certification, research and publications.
- Published in Press Release